The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: Executive summary

Journal of Heart and Lung Transplantation

Volumn 33, Issue 9, 2014, Pages 888-909

  Kirk, Richard ^a   Dipchand, Anne I ^b   Rosenthal, David N ^c   Addonizio, Linda ^d   Burch, Michael ^e   Chrisant, Maryanne ^f   Dubin, Anne ^c   Everitt, Melanie ^g   Gajarski, Robert ^h   Mertens, Luc ^b   Miyamoto, Shelley ⁱ   Morales, David ^j   Pahl, Elfriede ^k   Shaddy, Robert ^l   Towbin, Jeffrey ^j   Weintraub, Robert ^m  

^a FREEMAN HOSPITAL   (United Kingdom)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c STANFORD UNIVERSITY   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f JOE DIMAGGIO CHILDREN S HOSPITAL   (United States)

^g PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ CHILDREN S HOSPITAL   (United States)

^j CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^k CHILDREN'S MEMORIAL HOSPITAL   (United States)

^l CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^m ROYAL MELBOURNE HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; CORTICOSTEROID; DIGITALIS GLYCOSIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; ISOSORBIDE DINITRATE; MINERALOCORTICOID ANTAGONIST; NESIRITIDE; PHOSPHODIESTERASE INHIBITOR; RENIN INHIBITOR; THYROID HORMONE; VASODILATOR AGENT; VASOPRESSIN RECEPTOR ANTAGONIST;

ABLATION THERAPY; ACUTE HEART FAILURE; AMBULATORY MONITORING; ANEMIA; ARTIFICIAL HEART PACEMAKER; ASSISTED CIRCULATION; ASSISTED VENTILATION; BIVENTRICULAR ASSIST DEVICE; BRONCHOSCOPY; CACHEXIA; CARDIAC IMAGING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD; CHILDHOOD DISEASE; COGNITION; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; DEPRESSION; DIASTOLIC HEART FAILURE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FLUID THERAPY; GENE MUTATION; GENETIC SCREENING; HEALTH CARE DELIVERY; HEART BLOCK; HEART CATHETERIZATION; HEART FAILURE; HEART HEMODYNAMICS; HEART OUTPUT; HEART PALPITATION; HEART PERFORMANCE; HEART RATE; HEART RIGHT VENTRICLE DYSPLASIA; HEART SINGLE VENTRICLE; HEART VENTRICLE ARRHYTHMIA; HOME MONITORING; HORMONE SUBSTITUTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOMODULATION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFECTION; KIDNEY DYSFUNCTION; LUNG FUNCTION TEST; MALNUTRITION; MEDICAL SOCIETY; METABOLIC SYNDROME X; MOOD DISORDER; NEAR INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITION; PACEMAKER IMPLANTATION; PALLIATIVE THERAPY; POLYSOMNOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SLEEP; SOCIAL PSYCHOLOGY; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE; TACHYCARDIA INDUCED CARDIOMYOPATHY; THORAX RADIOGRAPHY; TISSUE DOPPLER IMAGING; TREATMENT INDICATION; VENTRICULAR NONCOMPACTION; ADOLESCENT; AGE; CARDIOVASCULAR SURGERY; DISEASE MANAGEMENT; DRUG THERAPY; HEART TRANSPLANTATION; INFANT; PRESCHOOL CHILD;

ADOLESCENT; AGE FACTORS; CARDIOVASCULAR SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; DISEASE MANAGEMENT; DRUG THERAPY; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; INFANT;

EID: 84921842891     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.06.002     Document Type: Article

References (160)

1. D. Rosenthal, M.R.K. Chrisant, E. Edens, and et al. International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children J Heart Lung Transplant 23 2004 1313 1333
2. U. S. Task Force Staff Guide to Clinical Preventive Services: report of the U.S. Preventive Services Task Force 1989 Diane Publishing Co Derby, PA 24
3. Kirk Richard, and D.N.R. Anne I Dipchand ISHLT guidelines for the management of pediatric heart failure 2014 University of Alabama at Birmingham Birmingham, AL
4. D.T. Hsu, and G.D. Pearson Heart failure in children: part I: history, etiology, and pathophysiology Circ Heart Fail 2 2009 63 70
5. R.D. Ross The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision Pediatr Cardiol 33 2012 1295 1300
6. A. Ferlini, M. Neri, and F. Gualandi The medical genetics of dystrophinopathies: molecular genetic diagnosis and its impact on clinical practice Neuromuscul Disord 23 2013 4 14
7. N.E. Bowles, K.R. Bowles, and J.A. Towbin The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy Herz 25 2000 168 175
8. M.K. Baig, J.H. Goldman, A.L. Caforio, A.S. Coonar, P.J. Keeling, and W.J. McKenna Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease J Am Coll Cardiol 31 1998 195 201
9. M.J. Ackerman, S.G. Priori, S. Willems, and et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) Heart Rhythm 8 2011 1308 1339
10. L. Mestroni, and M.R.G. Taylor Genetics and genetic testing of dilated cardiomyopathy: a new perspective Discov Med 15 2013 43 49
11. L. Thierfelder, H. Watkins, C. MacRae, and et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere Cell 77 1994 701 712
12. P. Teekakirikul, M.A. Kelly, H.L. Rehm, N.K. Lakdawala, and B.H. Funke Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era J Mol Diagn 15 2013 158 170
13. S.J. Kindel, E.M. Miller, R. Gupta, and et al. Pediatric cardiomyopathy: importance of genetic and metabolic evaluation J Card Fail 18 2012 396 403
14. C. Caleshu, R. Sakhuja, R.L. Nussbaum, and et al. Furthering the link between the sarcomere and primary cardiomyopathies: restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy Am J Med Genet A 155A 2011 2229 2235
15. S. Sen-Chowdhry, P. Syrris, and W.J. McKenna Genetics of restrictive cardiomyopathy Heart Fail Clin 6 2010 179 186
16. S. Tang, A. Batra, Y. Zhang, E.S. Ebenroth, and T. Huang Left ventricular noncompaction is associated with mutations in the mitochondrial genome Mitochondrion 10 2010 350 357
17. F.I. Marcus, W.J. McKenna, D. Sherrill, and et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria Eur Heart J 31 2010 806 814
18. M. Vatta, F. Marcus, and J.A. Towbin Arrhythmogenic right ventricular cardiomyopathy: a "final common pathway" that defines clinical phenotype Eur Heart J 28 2007 529 530
19. M. Cantinotti, S. Giovannini, B. Murzi, and A. Clerico Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases Clin Chem Lab Med 49 2011 567 580
20. J.F. Price, A.K. Thomas, M. Grenier, and et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left left ventricular systolic dysfunction Circulation 114 2006 1063 1069
21. W. Knirsch, E. Häusermann, M. Fasnacht, M. Hersberger, P. Gessler, and U. Bauersfeld Plasma B-type natriuretic peptide levels in children with heart disease Acta Paediatr 100 2011 1213 1216
22. Y.M. Law, A.W. Hoyer, M.D. Reller, and M. Silberbach Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study J Am Coll Cardiol 54 2009 1467 1475
23. S.R. Auerbach, M.E. Richmond, J.M. Lamour, and et al. BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial Circ Heart Fail 3 2010 606 611
24. L. Lopez, S.D. Colan, P.C. Frommelt, and et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council J Am Soc Echocardiogr 23 2010 465 495 [quiz 576-7]
25. N.B. Schiller, P.M. Shah, M. Crawford, and et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
26. M.K. Friedberg, and L. Mertens Echocardiographic assessment of ventricular synchrony in congenital and acquired heart disease in children Echocardiography 30 2013 460 471
27. C. Petko, L.L. Minich, M.D. Everitt, R. Holubkov, R.E. Shaddy, and L.Y. Tani Echocardiographic evaluation of children with systemic ventricular dysfunction treated with carvedilol Pediatr Cardiol 31 2010 780 784
28. S.D. Colan, G. Shirali, R. Margossian, and et al. The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy J Am Soc Echocardiogr 25 2012 842 854 (e6)
29. V. Mor-Avi, R.M. Lang, L.P. Badano, and et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography Eur J Echocardiogr 12 2011 167 205
30. M.K. Friedberg, and L. Mertens Tissue velocities, strain, and strain rate for echocardiographic assessment of ventricular function in congenital heart disease Eur J Echocardiogr 10 2009 585 593
31. A. Dragulescu, L. Mertens, and M.K. Friedberg Interpretation of left ventricular diastolic dysfunction in children with cardiomyopathy by echocardiography: problems and limitations Circ Cardiovasc Imaging 6 2013 254 261
32. S. Sarikouch, B. Peters, M. Gutberlet, and et al. Sex-specific pediatric percentiles for ventricular size and mass as reference values for cardiac MRI: assessment by steady-state free-precession and phase-contrast MRI flow Circ Cardiovasc Imaging 3 2010 65 76
33. E.V. Buechel, T. Kaiser, C. Jackson, A. Schmitz, and C.J. Kellenberger Normal right- and left ventricular volumes and myocardial mass in children measured by steady state free precession cardiovascular magnetic resonance J Cardiovasc Magn Reson 11 2009 19
34. E.B. Tham, R.W. Hung, K.A. Myers, C. Crawley, and M.L. Noga Optimization of myocardial nulling in pediatric cardiac MRI Pediatr Radiol 42 2012 431 439
35. W.A. Helbing, H.G. Bosch, C. Maliepaard, and et al. Comparison of echocardiographic methods with magnetic resonance imaging for assessment of right ventricular function in children Am J Cardiol 76 1995 589 594
36. C.F. Mooij, C.J. de Wit, D.A. Graham, A.J. Powell, and T. Geva Reproducibility of MRI measurements of right ventricular size and function in patients with normal and dilated ventricles J Magn Reson Imaging 28 2008 67 73
37. A.M. Maceira, S.K. Prasad, M. Khan, and D.J. Pennell Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance Eur Heart J 27 2006 2879 2888
38. R. Margossian, M.L. Schwartz, A. Prakash, and et al. Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study) Am J Cardiol 104 2009 419 428
39. A. Giardini, M. Fenton, R.E. Andrews, G. Derrick, and M. Burch Peak oxygen uptake correlates with survival without clinical deterioration in ambulatory children with dilated cardiomyopathy Circulation 124 2011 1713 1718
40. C.E. Canter, R.E. Shaddy, D. Bernstein, and et al. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Circulation 115 2007 658 676
41. S. Nadar, N. Prasad, R.S. Taylor, and G.Y. Lip Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta-analysis Int J Cardiol 99 2005 171 185
42. E. Pahl, L.A. Sleeper, C.E. Canter, and et al. Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry J Am Coll Cardiol 59 2012 607 615
43. D.N. Rosenthal, A.M. Dubin, C. Chin, D. Falco, P. Gamberg, and D. Bernstein Outcome while awaiting heart transplantation in children: a comparison of congenital heart disease and cardiomyopathy J Heart Lung Transplant 19 2000 751 755
44. F.P. Sarasin, D. Carballo, S. Slama, and M. Louis-Simonet Usefulness of 24-h Holter monitoring in patients with unexplained syncope and a high likelihood of arrhythmias Int J Cardiol 101 2005 203 207
45. T.F. Feltes, E. Bacha, R.H. Beekman, and et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association Circulation 123 2011 2607 2652
46. S.A. Hunt, W.T. Abraham, M.H. Chin, and et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 112 2005 e154 e235
47. L.T. Cooper, K.L. Baughman, A.M. Feldman, and et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Circulation 116 2007 2216 2233
48. A.J. Hauck, D.L. Kearney, and W.D. Edwards Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error Mayo Clin Proc 64 1989 1235 1245
49. T. Masuyama, K. Kodama, A. Kitabatake, H. Sato, S. Nanto, and M. Inoue Continuous-wave Doppler echocardiographic detection of pulmonary regurgitation and its application to noninvasive estimation of pulmonary artery pressure Circulation 74 1986 484 492
50. R. Benza, R. Biederman, S. Murali, and H. Gupta Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension J Am Coll Cardiol 52 2008 1683 1692
51. A. Garson, P.C. Gillette, and D.G. McNamara Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients J Pediatr 98 1981 875 882
52. Z. Donghua, P. Jian, X. Zhongbo, and et al. Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia J Interv Card Electrophysiol 36 2013 27 32 [discussion 32]
53. S.A. Hunt, W.T. Abraham, M.H. Chin, and et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 90
54. J.O. Parker The effects of oral ibopamine in patients with mild heart failure - a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group Int J Cardiol 40 1993 221 227
55. J.S. Li, S.D. Colan, L.A. Sleeper, and et al. Lessons learned from a pediatric clinical trial: the Pediatric Heart Network angiotensin-converting enzyme inhibition in mitral regurgitation study Am Heart J 161 2011 233 240
56. A.B. Lewis, and M. Chabot The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy Pediatr Cardiol 14 1993 9 12
57. P.F. Kantor, J.R. Abraham, A.I. Dipchand, L.N. Benson, and A.N. Redington The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy J Am Coll Cardiol 55 2010 1377 1384
58. D. Duboc, C. Meune, G. Lerebours, J.-Y. Devaux, G. Vaksmann, and H.-M. Bécane Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy J Am Coll Cardiol 45 2005 855 857
59. D. Duboc, C. Meune, B. Pierre, and et al. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up Am Heart J 154 2007 596 602
60. M. Packer, A.J. Coats, M.B. Fowler, and et al. Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
61. R.E. Shaddy, M.M. Boucek, D.T. Hsu, and et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial JAMA 298 2007 1171 1179
62. S. Albers, B. Meibohm, T.S. Mir, and S. Läer Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure Br J Clin Pharmacol 65 2008 511 522
63. B. Pitt, F. Zannad, W.J. Remme, and et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
64. B. Pitt, P.A. Poole-Wilson, R. Segal, and et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II Lancet 355 2000 1582 1587
65. J. Lindenfeld, N.M. Albert, J.P. Boehmer, and et al. HFSA 2010 comprehensive heart failure practice guideline J Card Fail 16 2010 e1 194
66. Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
67. J.N. Cohn, D.G. Archibald, S. Ziesche, and et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study N Engl J Med 314 1986 1547 1552
68. E. Pahl, L.A. Sleeper, C.E. Canter, and et al. Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry J Am Coll Cardiol 59 2012 607 615
69. B.M. Massie, J.F. Collins, S.E. Ammon, and et al. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial Circulation 119 2009 1616 1624
70. S. Homma, J.L.P. Thompson, P.M. Pullicino, and et al. Warfarin and aspirin in patients with heart failure and sinus rhythm N Engl J Med 366 2012 1859 1869
71. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002;287:1531-1540 (erratum in JAMA 2002;288:577).
72. J.D. Sackner-Bernstein, M. Kowalski, M. Fox, and K. Aaronson Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials JAMA 293 2005 1900 1905
73. A.M. Berg, L. Snell, and W.T. Mahle Home inotropic therapy in children J Heart Lung Transplant 26 2007 453 457
74. S.A. Hunt, W.T. Abraham, M.H. Chin, and et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
75. M.A. Konstam, M. Gheorghiade, J.C. Burnett, and et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 2007 1319 1331
76. G. Valania, M. Singh, and M.T. Slawsky Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists? Curr Heart Fail Rep 8 2011 198 205
77. H. Senzaki, M. Kamiyama, S. Masutani, and et al. Efficacy and safety of torasemide in children with heart failure Arch Dis Child 93 2008 768 771
78. R.V. Shah, A.S. Desai, and M.M. Givertz The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis J Card Fail 16 2010 260 267
79. S. Yusuf, M.A. Pfeffer, K. Swedberg, and et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
80. B.M. Massie, P.E. Carson, J.J. McMurray, and et al. Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
81. J.F. Setaro, B.L. Zaret, D.S. Schulman, H.R. Black, and R. Soufer Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance Am J Cardiol 66 1990 981 986
82. M.J. Hung, W.J. Cherng, C.H. Wang, and L.T. Kuo Effects of verapamil in normal elderly individuals with left ventricular diastolic dysfunction Echocardiography 18 2001 123 129
83. F. Edelmann, R. Wachter, A.G. Schmidt, and et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial JAMA 309 2013 781 791
84. M.M. Redfield, H.H. Chen, B.A. Borlaug, and et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA 309 2013 1268 1277
85. M. Guazzi, M. Vicenzi, R. Arena, and M.D. Guazzi Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study Circulation 124 2011 164 174
86. R.M. Califf, K.F. Adams, W.J. McKenna, and et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST) Am Heart J 134 1997 44 54
87. A. Lazarus, J. Varin, D. Babuty, F. Anselme, J. Coste, and D. Duboc Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study J Am Coll Cardiol 40 2002 1645 1652
88. J. Janousek, I.E. van Geldorp, S. Krupickova, and et al. Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study Circulation 127 2013 613 623
89. A.M. Dubin, J. Janousek, E. Rhee, and et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study J Am Coll Cardiol 46 2005 2277 2283
90. J. Janousek, R.A. Gebauer, H. Abdul-Khaliq, and et al. Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates Heart 95 2009 1165 1171
91. F. Cecchin, P.A. Frangini, D.W. Brown, and et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution J Cardiovasc Electrophysiol 20 2009 58 65
92. A.J. Moss, W.J. Hall, D.S. Cannom, and et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med 335 1996 1933 1940
93. E.K. Rhee, C.E. Canter, S. Basile, S.A. Webber, and D.C. Naftel Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome? J Heart Lung Transpl 26 2007 447 452
94. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators N Engl J Med 337 1997 1576 1583
95. C.S. Almond, D.L. Morales, E.H. Blackstone, and et al. Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children Circulation 127 2013 1702 1711
96. C.D. Fraser, R.D.B. Jaquiss, D.N. Rosenthal, and et al. Prospective trial of a pediatric ventricular assist device N Engl J Med 367 2012 532 541
97. R. Hetzer, V. Alexi-Meskishvili, Y. Weng, and et al. Mechanical cardiac support in the young with the Berlin Heart EXCOR pulsatile ventricular assist device: 15 years' experience Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006 99 108
98. S.A. Teele, C.K. Allan, P.C. Laussen, J.W. Newburger, K. Gauvreau, and R.R. Thiagarajan Management and outcomes in pediatric patients presenting with acute fulminant myocarditis J Pediatr 158 2011 638 643 (e1)
99. D.A. Kane, R.R. Thiagarajan, D. Wypij, and et al. Rapid-response extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in children with cardiac disease Circulation 122 11 Suppl 2010 S241 S248
100. N.M. Hunkeler, C.E. Canter, A. Donze, and T.L. Spray Extracorporeal life support in cyanotic congenital heart disease before cardiovascular operation Am J Cardiol 69 1992 790 793
101. J.K. Kirklin, D.C. Naftel, R.L. Kormos, and et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting J Heart Lung Transplant 31 2012 117 126
102. J.T. Baldwin, H.S. Borovetz, B.W. Duncan, M.J. Gartner, R.K. Jarvik, and W.J. Weiss The national heart, lung, and blood institute pediatric circulatory support program: a summary of the 5-year experience Circulation 123 2011 1233 1240
103. K.L. Booth, S.J. Roth, R.R. Thiagarajan, M.C. Almodovar, P.J. Del Nido, and P.C. Laussen Extracorporeal membrane oxygenation support of the Fontan and bidirectional Glenn circulations Ann Thorac Surg 77 2004 1341 1348
104. C.K. Allan, R.R. Thiagarajan, P.J. del Nido, S.J. Roth, M.C. Almodovar, and P.C. Laussen Indication for initiation of mechanical circulatory support impacts survival of infants with shunted single-ventricle circulation supported with extracorporeal membrane oxygenation J Thorac Cardiovasc Surg 133 2007 660 667
105. P. Russo, A. Wheeler, J. Russo, and J.D. Tobias Use of a ventricular assist device as a bridge to transplantation in a patient with single ventricle physiology and total cavopulmonary anastomosis Paediatr Anaesth 18 2008 320 324
106. R. Prêtre, A. Häussler, D. Bettex, and M. Genoni Right-sided univentricular cardiac assistance in a failing Fontan circulation Ann Thorac Surg 86 2008 1018 1020
107. E.J. Birks, P.D. Tansley, J. Hardy, and et al. Left ventricular assist device and drug therapy for the reversal of heart failure N Engl J Med 355 2006 1873 1884
108. J.K. Ghali, I.S. Anand, W.T. Abraham, and et al. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia Circulation 117 2008 526 535
109. S.A. Hunt ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guideli J Am Coll Cardiol 46 2005 e1 82
110. W.T. Mahle, A.M. Berg, and K.R. Kanter Red blood cell transfusions in children awaiting heart transplantation Pediatr Transplant 15 2011 728 732
111. L. Tavazzi, M. Senni, M. Metra, and et al. Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry Circ Heart Fail 6 2013 473 481
112. Z. Ricci, M. Di Nardo, C. Iacoella, R. Netto, S. Picca, and P. Cogo Pediatric RIFLE for acute kidney injury diagnosis and prognosis for children undergoing cardiac surgery: a single-center prospective observational study Pediatr Cardiol 34 2013 1404 1408
113. A. Akcan-Arikan, M. Zappitelli, L.L. Loftis, K.K. Washburn, L.S. Jefferson, and S.L. Goldstein Modified RIFLE criteria in critically ill children with acute kidney injury Kidney Int 71 2007 1028 1035
114. J.P. Guillemaud, H. El-Hakim, S. Richards, and N. Chauhan Airway pathologic abnormalities in symptomatic children with congenital cardiac and vascular disease Arch Otolaryngol Head Neck Surg 133 2007 672 676
115. F. Healy, B.D. Hanna, and R. Zinman Pulmonary complications of congenital heart disease Paediatr Respir Rev 13 2012 10 15
116. L.K. Pickering American Academy of Pediatrics Red Book: 2012 report of the Committee on Infectious Diseases 29th ed. 2012 American Academy of Pediatrics Elk Grove Village
117. L. Danziger-Isakov, and D. Kumar Vaccination in solid organ transplantation Am J Transplant 13 Suppl 4 2013 311 317
118. W.J. Evans, J.E. Morley, J. Argilés, and et al. Cachexia: a new definition Clin Nutr 27 2008 793 799
119. S.D. Anker, A. Negassa, A.J. Coats, and et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study Lancet 361 2003 1077 1083
120. D. Secker Promoting optimal monitoring of child growth in Canada: using the new WHO growth charts Can J Diet Pract Res 71 2010 e1 e3
121. R.M. Cubbon, B. Adams, A. Rajwani, and et al. Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology Diab Vasc Dis Res 10 2013 330 336
122. R. Weiss, J. Dziura, T.S. Burgert, and et al. Obesity and the metabolic syndrome in children and adolescents N Engl J Med 350 2004 2362 2374
123. J. Menteer, V.N. Beas, J.C. Chang, K. Reed, and J.I. Gold Mood and health-related quality of life among pediatric patients with heart failure Pediatr Cardiol 34 2013 431 437
124. J. Menteer, P.M. Macey, M.A. Woo, A. Panigrahy, and R.M. Harper Central nervous system changes in pediatric heart failure: a volumetric study Pediatr Cardiol 31 2010 969 976
125. B. Ozbaran, S. Kose, T. Yagdi, and et al. Psychiatric evaluation of children and adolescents with left ventricular assist devices Psychosom Med 74 2012 554 558
126. A.D. Staniforth, W.J. Kinnear, and A.J. Cowley Cognitive impairment in heart failure with Cheyne-Stokes respiration Heart 85 2001 18 22
127. R.A. Bornstein, R.C. Starling, P.D. Myerowitz, and G.J. Haas Neuropsychological function in patients with end-stage heart failure before and after cardiac transplantation Acta Neurol Scand 91 1995 260 265
128. M.L. Stein, J.L. Bruno, K.L. Konopacki, S. Kesler, O. Reinhartz, and D. Rosenthal Cognitive outcomes in pediatric heart transplant recipients bridged to transplantation with ventricular assist devices J Heart Lung Transplant 32 2013 212 220
129. K. Rees, R.S. Taylor, S. Singh, A.J.S. Coats, and S. Ebrahim Exercise based rehabilitation for heart failure Cochrane Database Syst Rev 2004 (CD003331)
130. G.V. Guimarães, G. Bellotti, A.O. Mocelin, P.R. Camargo, and E.A. Bocchi Cardiopulmonary exercise testing in children with heart failure secondary to idiopathic dilated cardiomyopathy Chest 120 2001 816 824
131. S.M. Macicek, C.G. Macias, J.L. Jefferies, J.J. Kim, and J.F. Price Acute heart failure syndromes in the pediatric emergency department Pediatrics 124 2009 e898 e904
132. J.J.V. McMurray, S. Adamopoulos, S.D. Anker, and et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
133. K.L. Grady, K. Dracup, G. Kennedy, and et al. Team management of patients with heart failure: a statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association Circulation 102 2000 2443 2456
134. V. Ben Sivarajan, and D. Bohn Monitoring of standard hemodynamic parameters: Heart rate, systemic blood pressure, atrial pressure, pulse oximetry, and end-tidal CO2 Pediatr Crit Care Med 12 2011 S2 11
135. K. Taylor, C. Manlhiot, B. McCrindle, L. Grosse-Wortmann, and H. Holtby Poor accuracy of noninvasive cardiac output monitoring using bioimpedance cardiography [PhysioFlow(R)] compared to magnetic resonance imaging in pediatric patients Anesth Analg 114 2012 771 775
136. U. Elkayam, G. Tasissa, C. Binanay, and et al. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure Am Heart J 153 2007 98 104
137. T.M. Hoffman Newer inotropes in pediatric heart failure J Cardiovasc Pharmacol 58 2011 121 125
138. L.M. Ryerson, P.M.A. Alexander, W.W. Butt, F.A. Shann, D.J. Penny, and L.S. Shekerdemian Rotating inotrope therapy in a pediatric population with decompensated heart failure Pediatr Crit Care Med 12 2011 57 60
139. M.A. Portman, A. Slee, A.K. Olson, and et al. Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis Circulation 122 2010 S224 S233
140. C. Liu, J. Chen, and K. Liu Immunosuppressive treatment for inflammatory cardiomyopathy: meta-analysis of randomized controlled trials Int Heart J 46 2005 113 122
141. H. Chen, J. Liu, and M. Yang Corticosteroids for viral myocarditis Cochrane database Syst Rev Online 2006 (CD004471)
142. A. Nohria, S.W. Tsang, J.C. Fang, and et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure J Am Coll Cardiol 41 2003 1797 1804
143. J.M. Testani, J. Chen, B.D. McCauley, S.E. Kimmel, and R.P. Shannon Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival Circulation 122 2010 265 272
144. H.H. Chen, and R.W. Schrier Pathophysiology of volume overload in acute heart failure syndromes Am J Med 119 2006 S11 S16
145. S. Von Haehling, W. Doehner, and S.D. Anker Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure Cardiovasc Res 73 2007 298 309
146. M.A. Simon Assessment and treatment of right ventricular failure Nat Rev Cardiol 10 2013 204 218
147. T.M. Hoffman, G. Wernovsky, A.M. Atz, and et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease Circulation 107 2003 996 1002
148. T.M. Hoffman, G. Wernovsky, A.M. Atz, and et al. Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics (PRIMACORP) study Am Heart J 143 2002 15 21
149. J.R. Kaltman, D.B. Andropoulos, P.A. Checchia, and et al. Report of the Pediatric Heart Network and National Heart, Lung, and Blood Institute working group on the perioperative management of congenital heart disease Circulation 121 2010 2766 2772
150. R.D. Jaquiss, and R.A. Bronicki An overview of mechanical circulatory support in children Pediatr Crit Care Med 14 5 Suppl 1 2013 S3 S6
151. C.E. Canter, R.E. Shaddy, D. Bernstein, and et al. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Su Circulation 115 2007 658 676
152. M.R. Mehra, J. Kobashigawa, R. Starling, and et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006 J Heart Lung Transplant 25 2006 1024 1042
153. B.W. Jack, V.K. Chetty, D. Anthony, and et al. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial Ann Intern Med 150 2009 178 187
154. C.M. Clancy Reengineering hospital discharge: a protocol to improve patient safety, reduce costs, and boost patient satisfaction Am J Med Qual 24 2009 344 346
155. V.G. Florea, and I.S. Anand Clinical trial report: reevaluating telemonitoring in heart failure Curr Heart Fail Rep 8 2011 84 86
156. G. Giamouzis, D. Mastrogiannis, K. Koutrakis, and et al. Telemonitoring in chronic heart failure: a systematic review Cardiol Res Pract 2012 2012 410820
157. N. Ghanayem, G. Hoffman, K. Mussatto, and et al. Home surveillance program prevents interstage mortality after the Norwood procedure J Thorac Cardiovasc Surg 126 2003 1367 1375
158. L.E. Bell, and S.M. Sawyer Transition of care to adult services for pediatric solid-organ transplant recipients Pediatr Clin North Am 57 2010 593 610
159. C. LaRosa, C. Glah, H.J. Baluarte, and K.E.C. Meyers Solid-organ transplantation in childhood: transitioning to adult health care Pediatrics 127 2011 742 753
160. E. Morell, J. Wolfe, M. Scheurer, and et al. Patterns of care at end of life in children with advanced heart disease Arch Pediatr Adolesc Med 166 2012 745 748